Physician profile
Michael Awad
NPI 1023279965
$8,479.04
in general payments reported to CMS, 2019-2025
35 companies · $983 in 2025
The $983 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,718 · 2020: $245 · 2021: $521 · 2022: $795 · 2023: $3,611 · 2024: $605 · 2025: $983.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,609 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500 · Education: $90.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,608.96 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
| Education | $90.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $2,612.62 | 2023-2024 | |
| Abbvie INC. | $1,321.40 | 2019-2025 | Liletta, Orilissa, Lo Loestrin Fe |
| Baxter Healthcare | $955.17 | 2019-2025 | Perclot |
| Intuitive Surgical, INC. | $916.23 | 2019-2025 | Da Vinci Surgical System |
| Hologic Sales and Service, LLC | $638.01 | 2020-2025 | Acessa Provu System, Myosure Tissue Removal Device, Novasure |
| Astellas Pharma US INC | $237.05 | 2023-2025 | Veozah |
| Sumitomo Pharma America, INC. | $223.18 | 2023-2025 | Myfembree |
| Avion Pharmaceuticals | $188.00 | 2021-2023 | Balcoltra |
| Organon LLC | $129.68 | 2024-2025 | Nexplanon |
| Mimedx Group, INC. | $113.10 | 2025 | |
| Novo Nordisk INC | $110.90 | 2024-2025 | Wegovy |
| Biogen, INC. | $101.70 | 2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $86.29 | 2019-2020 | |
| Medtronic, INC. | $65.46 | 2023-2025 | V-Loc 180 |
| Lilly USA, LLC | $64.58 | 2025 | Zepbound |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $62.96 | 2019-2020 | |
| Allergan, INC. | $61.88 | 2019-2021 | |
| Becton, Dickinson and Company | $53.18 | 2023 | Bd Onclarity |
| Therapeuticsmd, INC. | $52.95 | 2019-2021 | |
| Exeltis, USA INC. | $48.35 | 2025 | Slynd |
| Agile Therapeutics, INC. | $48.12 | 2022 | |
| Mayne Pharma Commercial LLC | $46.99 | 2023 | |
| Lupin INC. | $39.68 | 2019 | |
| Merck Sharp & Dohme LLC | $38.55 | 2019-2020 | |
| Conmed Corporation | $38.46 | 2023 | Airseal |
| Scynexis, INC. | $35.69 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $28.93 | 2023 | |
| Medicem INC. | $26.72 | 2020 | |
| Integra Lifesciences Corporation | $24.41 | 2024 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Myovant Sciences INC. | $23.03 | 2021 | |
| Abbott Laboratories | $22.23 | 2025 | Proclaim |
| Horizon Therapeutics Plc | $19.92 | 2021 | |
| Evofem Biosciences, INC. | $16.25 | 2022 | |
| Dysis Medical, INC. | $14.18 | 2022 | |
| Mission Pharmacal Company | $13.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Awad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.